Regentis Biomaterials (NYSE American: RGNT) grants 24,826 options to director
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Regentis Biomaterials Ltd. granted Director Susan Alpert an employee stock option for 24,826 Ordinary Shares at an exercise price of $2.16 per share. The grant, approved by the board on June 4, 2026 and subject to shareholder approval, became effective after shareholders approved it on July 9, 2026. The options vest in twelve quarterly installments starting September 4, 2026 and continue through June 4, 2029, and expire on June 4, 2036. Following this grant, Alpert holds options for 24,826 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Alpert Susan PHD MD
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) | 24,826 | $0.00 | -- |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 24,826 shares (Direct)
Footnotes (1)
- This option grant was approved by the Board of Directors of the Issuer on June 4, 2026, subject to shareholder approval, which was obtained on July 9, 2026. This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on September 4, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or June 4, 2029.
Key Figures
Options Granted: 24,826 options
Exercise Price: $2.1600 per share
Total Options After Grant: 24,826 options
+3 more
6 metrics
Options Granted
24,826 options
Employee stock option grant to Director Susan Alpert
Exercise Price
$2.1600 per share
Conversion or exercise price of the employee stock option
Total Options After Grant
24,826 options
Total derivative securities held following the reported transaction
First Vesting Date
September 4, 2026
First 1/12 of options vest on this date
Full Vesting Date
June 4, 2029
Options fully vest on the third anniversary of the grant date
Expiration Date
June 4, 2036
Expiration date of the employee stock option
Key Terms
Employee Stock Option (Right to Buy), exercise price, vest on a quarterly basis, subject to shareholder approval, +1 more
5 terms
Employee Stock Option (Right to Buy) financial
"security title is listed as Employee Stock Option (Right to Buy)"
exercise price financial
"conversion or exercise price of $2.1600 per share is specified"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest on a quarterly basis financial
"options grant shall vest on a quarterly basis, with one-twelfth vesting"
expiration date financial
"derivative security shows an expiration date of 2036-06-04"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What insider transaction did RGNT director Susan Alpert report?
Director Susan Alpert reported a grant of employee stock options for 24,826 Ordinary Shares of RGNT. The options carry a $2.16 exercise price, were granted as compensation, and do not reflect any open-market purchase or sale of shares.
How many RGNT options were granted to Susan Alpert and at what price?
Susan Alpert received an option covering 24,826 Ordinary Shares of RGNT at an exercise price of $2.16 per share. The grant price reflects the cost to exercise the options in the future, not an immediate cash transaction.
What is the vesting schedule of Susan Alpert’s RGNT stock options?
The options vest quarterly over three years, with 1/12 vesting on September 4, 2026, and another 1/12 on the last day of each subsequent three-month period. Vesting continues until June 4, 2029, subject to her continuous employment.
When do Susan Alpert’s RGNT options expire and when can they first be exercised?
The options are first scheduled to vest on September 4, 2026, after which vested portions may be exercisable subject to plan terms. The entire option position has an expiration date of June 4, 2036, after which any unexercised options lapse.
How many RGNT options does Susan Alpert hold after this grant?
After this grant, Susan Alpert holds 24,826 stock options directly, each relating to one Ordinary Share of RGNT. This total reflects the full amount of the new grant as her derivative holdings reported in this filing.